United States · Venture startup

Who invested in Revance Therapeutics

7 rounds we have observed, with the 11 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Funding summaryUpdated 26 Oct 2026

$256Mraised across 7 rounds since 2007, from 7 sources

$43MSeries C$26MSeries D$36MSeries D$45MSeries D$63MVenture$33MSeries E$10MVenture
Latest round
Venture, $10MOct 2013
Biggest round
$63MVenture · Jan 2013
Investors
11
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

200820092010201120122013
$43MSeries C$26MSeries D$36MSeries D$45MSeries D$63MVenture$33MSeries E$10MVenture
First round
Series C, $43M
Dec 2007
Biggest round
$63M
Venture · Jan 2013
Usual gap between rounds
10 months
the median of 6

The rounds

  1. Oct 2013
    Venture$10M

    No investor was named in the report.

    Reported by pevc.dowjones.comSEC filing: $10M sold, first sale Oct 2013

  2. Apr 2013
    Series E$33M1 new2 returning

    Reported by biocentury.comSEC filing: $5.0M sold, first sale Feb 2013

  3. Jan 2013
    Venture$63M

    No investor was named in the report.

    Reported by sec.govSEC filing: $63M sold, first sale Jan 2011

  4. Jun 2011
    Series D$45M2 new5 returning

    Reported by finsmes.comSEC filing: $45M sold, first sale Jan 2011

  5. Nov 2010
    Series D$36M2 new3 returning

    Reported by sec.govSEC filing: $36M sold, first sale Dec 2009

  6. Dec 2009
    Series D$26M

    No investor was named in the report.

    From a historical funding recordSEC filing: $26M sold, first sale Dec 2009

  7. Dec 2007
    Series C$43M6 new

    From a historical funding record

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Series C2007Series D2009Series D2010Series D2011Venture2013Series E2013Venture2013Essex Woodlands Healthcare PartnersVivo VenturesShepherd VenturesTechnology PartnersPalo Alto InvestorsQuintilesDelphi VenturesCNF InvestmentsTechnology Venture PartnersPac-Link

Everyone who backed them

Essex Woodlands Healthcare PartnersVC firm4rounds
Vivo VenturesVC firm3rounds
Shepherd VenturesVC firm3rounds
Technology PartnersHedge fund2rounds
Palo Alto InvestorsGrowth equity2rounds
QuintilesCorporate VC2rounds
Delphi VenturesVC firm1round
CNF InvestmentsVC firm1round
Technology Venture PartnersGrowth equity1round
Pac-LinkVC firm1round
Medicis PharmaceuticalGrowth equity1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Revance Therapeutics

Who invested in Revance Therapeutics?

Revance Therapeutics's investors include Essex Woodlands Healthcare Partners, Vivo Ventures, Shepherd Ventures, Technology Partners and Palo Alto Investors, and 6 more on record.

How much has Revance Therapeutics raised?

Revance Therapeutics has raised $256M across 7 rounds since 2007.

When did Revance Therapeutics last raise?

Revance Therapeutics's most recent round was a Venture of $10M in Oct 2013.

What was Revance Therapeutics's biggest round?

Revance Therapeutics's largest round on record is $63M (Venture), in Jan 2013.

Who backed Revance Therapeutics first?

Revance Therapeutics's first round on record, in Dec 2007, was backed by Essex Woodlands Healthcare Partners, Technology Partners and Vivo Ventures and 3 others.

What stage is Revance Therapeutics at?

Revance Therapeutics's latest named round is a Venture, in Oct 2013.

Where is Revance Therapeutics based?

Revance Therapeutics is based in the United States.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.

Open the investor searchOr these rounds in the app